Skip to main content

Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III.

Publication ,  Journal Article
Schwartz, GG; Il'yasova, D; Ivanova, A
Published in: Diabetes Care
February 2003

OBJECTIVE: Increasing rates of type 2 diabetes worldwide suggest that diabetes may be caused by environmental toxins. Cadmium is a widespread environmental pollutant that accumulates in the pancreas and exerts diabetogenic effects in animals. To test the hypothesis that exposure to cadmium is associated with impaired fasting glucose and type 2 diabetes, we examined the associations between urinary cadmium and the prevalence of impaired fasting glucose (prediabetes) and diabetes in the Third National Health and Nutrition Examination Survey (NHANES III). RESEARCH DESIGN AND METHODS: We analyzed data on 8,722 adults > or =40 years of age from the NHANES III (1988-1994), a cross-sectional health survey of a nationally representative sample of the noninstitutionalized civilian U.S. population. We studied urinary levels of cadmium (adjusted for urine creatinine) in relation to the prevalence of impaired fasting glucose and diabetes, using the criteria of the American Diabetes Association. RESULTS: After adjustment for age, ethnicity, sex, and BMI, the odds of impaired fasting glucose and diabetes increased dose-dependently with elevations in urinary cadmium from 0-0.99 to 1.00-1.99 and > or =2 micro g/g creatinine (impaired fasting glucose, odds ratio [OR] 1.48, 95% CI 1.21-1.82 and OR 2.05, 95% CI 1.42-2.95; diabetes, OR 1.24, 95% CI 1.06-1.45 and OR 1.45, 95% CI 1.07-1.97). CONCLUSIONS: In this large cross-sectional study, urinary cadmium levels are significantly and dose-dependently associated with both impaired fasting glucose and diabetes. These findings, which require confirmation in prospective studies, suggest that cadmium may cause prediabetes and diabetes in humans.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Diabetes Care

DOI

ISSN

0149-5992

Publication Date

February 2003

Volume

26

Issue

2

Start / End Page

468 / 470

Location

United States

Related Subject Headings

  • United States
  • Smoking
  • Prevalence
  • Osmolar Concentration
  • Odds Ratio
  • Nutrition Surveys
  • Humans
  • Fasting
  • Endocrinology & Metabolism
  • Diabetes Mellitus
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schwartz, G. G., Il’yasova, D., & Ivanova, A. (2003). Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care, 26(2), 468–470. https://doi.org/10.2337/diacare.26.2.468
Schwartz, Gary G., Dora Il’yasova, and Anastasia Ivanova. “Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III.Diabetes Care 26, no. 2 (February 2003): 468–70. https://doi.org/10.2337/diacare.26.2.468.
Schwartz GG, Il’yasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care. 2003 Feb;26(2):468–70.
Schwartz, Gary G., et al. “Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III.Diabetes Care, vol. 26, no. 2, Feb. 2003, pp. 468–70. Pubmed, doi:10.2337/diacare.26.2.468.
Schwartz GG, Il’yasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care. 2003 Feb;26(2):468–470.

Published In

Diabetes Care

DOI

ISSN

0149-5992

Publication Date

February 2003

Volume

26

Issue

2

Start / End Page

468 / 470

Location

United States

Related Subject Headings

  • United States
  • Smoking
  • Prevalence
  • Osmolar Concentration
  • Odds Ratio
  • Nutrition Surveys
  • Humans
  • Fasting
  • Endocrinology & Metabolism
  • Diabetes Mellitus